awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q53465288-CF288D0A-550B-41EC-81A0-F9C6736440D8
Q53465288-CF288D0A-550B-41EC-81A0-F9C6736440D8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53465288-CF288D0A-550B-41EC-81A0-F9C6736440D8
Schedule dependent synergy of gemcitabine and doxorubicin: Improvement of in vitro efficacy and lack of in vitro-in vivo correlation.
P2860
Q53465288-CF288D0A-550B-41EC-81A0-F9C6736440D8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53465288-CF288D0A-550B-41EC-81A0-F9C6736440D8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b6e015fd80bf468f4af5a2d08cb7d9ae57f3114b
P2860
Cross-species genomic and functional analyses identify a combination therapy using a CHK1 inhibitor and a ribonucleotide reductase inhibitor to treat triple-negative breast cancer.